Fehrenbach

Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovor-in for metastatic colorectal cancer. N Engl J Med 350 2335-2342... 

Fehrenbach H. Alveolar epithelial type n cell defender of the alveolus revisited. Respir Res 2001 2(1) 33 46. 

Fehrenbach H, Giegrich J, Mohler S (2007) Behandlungsaltemativen flir klimarelevante Stoffstrome, UBA-Texte 39/07, ISSN 1862 -804, Dessau... 

Fehrenbach H, Schmiedl A, Wahlers T, Hirt SW, Brasch F, Riemann D, Richter J (1995) Morphometric characterisation of the fine structure of human type II pneumocytes. Anat Rec 243(1 ) 49-62... 

Hermie L, Funfgeld M, Oepen G, Botsch H, Borchardt D, Gouzoulis E, Fehrenbach RA, Hirsch KS, Fritz HI. (1981). Teratogenic effects of mescaline, epinephrine, and norepinephrine in the hamster. Teratology. 23(3) 287-91. 

R. Fehrenbach, M. Comberbach and J.O. Petre, On-line biomass monitoring by capacitance measurement. J. 

Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bev-ers TB, Fehrenbacher L, Pajon ER Jr, Wade JL 111, Robidoux A, Margolese RG, James J, Lippman SM, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N (2006) JAMA 295 2727... 

Fehrenbacher K, HuckabaT, YangHC, Boldogh I,PonL (2003) Actin comet tails, endosomes and endosymbionts. J Exp Biol 206 1977-1984... 

Kabbinavar F Hurwitz HI, Fehrenbacher L, et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol 2003 21 60-65. 

Cobleigh, M. A., Vogel, C. L., Tripathy, D., Robert, N. J., Scholl, S., Fehrenbacher, L., Wolter, J. M., Paton, V., Shak, S., Lieberman, G., and Slamon, D. J. (1999). Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease./. Clin. Oncol. 17, 2639-2648. 

A direct comparison of some representative sensors to estimate biomass in bacterial and yeast cultures was made by Nipkow et al. [309], by Fehrenbach et al. [107], by Konstantinov et al. [219] and, more recently, by Wu et al. [465]. These studies are of importance because the sensors were mounted in situ and used in parallel. Most of the sensors measured the optical density (OD), one the autofluorescence of the cultures (fluorosensor) and another was a capacitance sensor (Cugmeter). 

H. Marquart, S. Maidment, J.L. McClaflin and M.C. Fehrenbacher, Harmonization of Future Needs for Dermal Exposure Assessment and Modelling A Workshop Report, Applied Occupational and Environmental Hygiene, 2003, 16,218. 

---